A diagnostic marker for superficial urothelial bladder carcinoma: Lack of nuclear ATBF1 (ZFHX3) by immunohistochemistry suggests malignant progression

BMC Cancer

Volumn 16, Issue 1, 2016, Pages

  Kawaguchi, Makoto ^a,b   Hara, Noboru ^c   Bilim, Vladimir ^c   Koike, Hiroshi ^a   Suzuki, Mituko ^d,e   Kim, Tae Sun ^b   Gao, Nan ^b   Dong, Yu ^b   Zhang, Sheng ^b,n   Fujinawa, Yuji ^a   Yamamoto, Osamu ^a   Ito, Hiromi ^f   Tomita, Yoshihiko ^c   Naruse, Yuchi ^g   Sakamaki, Akira ^h   Ishii, Yoko ^g   Tsuneyama, Koichi ⁱ   Inoue, Masaaki ^j   Itoh, Johbu ^k   Yasuda, Masanori ^l   Sakata, Nobuo ^m   Jung, Cha Gyun ^b   Kanazawa, Satoshi ^b   Akatsu, Hiroyasu ^b   Minato, Hiroshi ⁿ   Nojima, Takayuki ⁿ   Asai, Kiyofumi ^b   Miura, Yutaka ^b   more..

^a Japan Organization of Occupational Health and Safety   (Japan)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^c NIIGATA UNIVERSITY   (Japan)

^d University of Ghana   (Ghana)

^e TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^f YAMAGATA UNIVERSITY   (Japan)

^g UNIVERSITY OF TOYAMA   (Japan)

^h Ooshima Kurumi Hospital   (Japan)

ⁱ UNIVERSITY OF TOKUSHIMA   (Japan)

^j Shimonoseki City Hospital   (Japan)

^k TOKAI UNIVERSITY   (Japan)

^l SAITAMA MEDICAL UNIVERSITY   (Japan)

^m SHOWA PHARMACEUTICAL UNIVERSITY   (Japan)

ⁿ KANAZAWA MEDICAL UNIVERSITY   (Japan)

more..

Author keywords

ATBF1; Nuclear localization signals; Prognostic marker; Urothelial bladder carcinoma

Indexed keywords

AT MOTIF BINDING FACTOR 1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; HOMEODOMAIN PROTEIN; TUMOR MARKER; ZFHX3 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BLADDER CANCER CELL LINE; BLADDER CARCINOMA; CANCER GRADING; CANCER PROGNOSIS; CANCER STAGING; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONSENSUS SEQUENCE; CONTROLLED STUDY; CYTOPLASM; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NUCLEAR LOCALIZATION SIGNAL; OVERALL SURVIVAL; PROTEIN EXPRESSION; RECURRENCE FREE SURVIVAL; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; ANIMAL; BLADDER TUMOR; CHLOROCEBUS AETHIOPS; CV-1 CELL LINE; DISEASE COURSE; HEK293 CELL LINE; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; TUMOR CELL LINE; VERY ELDERLY; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BIOMARKERS, TUMOR; BLOTTING, WESTERN; CARCINOMA, TRANSITIONAL CELL; CELL LINE, TUMOR; CELL NUCLEUS; CERCOPITHECUS AETHIOPS; COS CELLS; CYTOPLASM; DISEASE PROGRESSION; FEMALE; HEK293 CELLS; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; URINARY BLADDER NEOPLASMS;

EID: 84992163063     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/s12885-016-2845-5     Document Type: Article

References (24)

1. Ro JY, Staerkel GA, Ayala AG. Cytologic and histologic features of superficial bladder cancer. Urol Clin North Am. 1992;19(3):435-53.
2. Matsushita K, Cha EK, Matsumoto K, Baba S, Chromecki TF, Fajkovic H, Sun M, Karakiewicz PI, Scherr DS, Shariat SF. Immunohistochemical biomarkers for bladder cancer prognosis. Int J Urol. 2011;18(9):616-29.
3. Morinaga T, Yasuda H, Hashimoto T, Higashio K, Tamaoki T. A human alpha-fetoprotein enhancer-binding protein, ATBF1, contains four homeodomains and seventeen zinc fingers. Mol Cell Biol. 1991;11(12):6041-9.
4. Yasuda H, Mizuno A, Tamaoki T, Morinaga T. ATBF1, a multiple-homeodomain zinc finger protein, selectively down-regulates AT-rich elements of the human alpha-fetoprotein gene. Mol Cell Biol. 1994;14(2):1395-401.
5. Sun X, Frierson HF, Chen C, Li C, Ran Q, Otto KB, Cantarel BL, Vessella RL, Gao AC, Petros J, et al. Frequent somatic mutations of the transcription factor ATBF1 in human prostate cancer. Nat Genet. 2005;37(4):407-12.
6. Xu J, Sauvageot J, Ewing CM, Sun J, Liu W, Isaacs SD, Wiley KE, Diaz L, Zheng SL, Walsh PC, et al. Germline ATBF1 mutations and prostate cancer risk. Prostate. 2006;66(10):1082-5.
7. Kataoka H, Miura Y, Joh T, Seno K, Tada T, Tamaoki T, Nakabayashi H, Kawaguchi M, Asai K, Kato T, et al. Alpha-fetoprotein producing gastric cancer lacks transcription factor ATBF1. Oncogene. 2001;20(7):869-73.
8. Cho YG, Song JH, Kim CJ, Lee YS, Kim SY, Nam SW, Lee JY, Park WS. Genetic alterations of the ATBF1 gene in gastric cancer. Clin Cancer Res. 2007;13(15 Pt 1):4355-9.
9. Sun X, Zhou Y, Otto KB, Wang M, Chen C, Zhou W, Subramanian K, Vertino PM, Dong JT. Infrequent mutation of ATBF1 in human breast cancer. J Cancer Res Clin Oncol. 2007;133(2):103-5.
10. Kai K, Zhang Z, Yamashita H, Yamamoto Y, Miura Y, Iwase H. Loss of heterozygosity at the ATBF1-A locus located in the 16q22 minimal region in breast cancer. BMC Cancer. 2008;8:262.
11. Mori Y, Kataoka H, Miura Y, Kawaguchi M, Kubota E, Ogasawara N, Oshima T, Tanida S, Sasaki M, Ohara H, et al. Subcellular localization of ATBF1 regulates MUC5AC transcription in gastric cancer. Int J Cancer. 2007;121(2):241-7.
12. Sun X, Li J, Sica G, Fan SQ, Wang Y, Chen Z, Muller S, Chen ZG, Fu X, Dong XY, et al. Interruption of nuclear localization of ATBF1 during the histopathologic progression of head and neck squamous cell carcinoma. Head Neck. 2012;35(7):1007-14.
13. Nishio E, Miura Y, Kawaguchi M, Morita A. Nuclear Translocation of ATBF1 Is a Potential Prognostic Marker for Skin Cancer. Acta Dermatovenerol Croat. 2012;20(4):239-45.
14. Ishii Y, Kawaguchi M, Takagawa K, Oya T, Nogami S, Tamura A, Miura Y, Ido A, Sakata N, Hashimoto-Tamaoki T, et al. ATBF1-A protein, but not ATBF1-B, is preferentially expressed in developing rat brain. J Comp Neurol. 2003;465(1):57-71.
15. Jung CG, Kim HJ, Kawaguchi M, Khanna KK, Hida H, Asai K, Nishino H, Miura Y. Homeotic factor ATBF1 induces the cell cycle arrest associated with neuronal differentiation. Development. 2005;132(23):5137-45.
16. Sun X, Li J, Dong FN, Dong JT. Characterization of nuclear localization and SUMOylation of the ATBF1 transcription factor in epithelial cells. PLoS One. 2014;9(3):e92746.
17. Zhang S, Kim TS, Dong Y, Kanazawa S, Kawaguchi M, Gao N, Minato H, Takegami T, Nojima T, Asai K, et al. AT motif binding factor 1 (ATBF1) is highly phosphorylated in embryonic brain and protected from cleavage by calpain-1. Biochem Biophys Res Commun. 2012;427(3):537-41.
18. Benham F, Cottell DC, Franks LM, Wilson PD. Alkaline phosphatase activity in human bladder tumor cell lines. J Histochem Cytochem. 1977;25(4):266-74.
19. Itoh M, Murata T, Suzuki T, Shindoh M, Nakajima K, Imai K, Yoshida K. Requirement of STAT3 activation for maximal collagenase-1 (MMP-1) induction by epidermal growth factor and malignant characteristics in T24 bladder cancer cells. Oncogene. 2006;25(8):1195-204.
20. Yamashita S, Miyagi C, Fukada T, Kagara N, Che YS, Hirano T. Zinc transporter LIVI controls epithelial-mesenchymal transition in zebrafish gastrula organizer. Nature. 2004;429(6989):298-302.
21. Nojiri S, Joh T, Miura Y, Sakata N, Nomura T, Nakao H, Sobue S, Ohara H, Asai K, Ito M. ATBF1 enhances the suppression of STAT3 signaling by interaction with PIAS3. Biochem Biophys Res Commun. 2004;314(1):97-103.
22. Eble JN, Sauter G, Epstein JI, Sesterhenn IA. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. International Agency for Research on Cancer (IARC) Press; 2004. p. 89-154.
23. Miura Y, Tam T, Ido A, Morinaga T, Miki T, Hashimoto T, Tamaoki T. Cloning and characterization of an ATBF1 isoform that expresses in a neuronal differentiation-dependent manner. J Biol Chem. 1995;270(45):26840-8.
24. Dignam JD, Martin PL, Shastry BS, Roeder RG. Eukaryotic gene transcription with purified components. Methods Enzymol. 1983;101:582-98.